London: BritainUS Health Secretary hails “incredible results” of testing pfizerExperimental antiviral pill for Kovid-19 that the country has procured 250,000 courses.
The US company said on Friday it had stopped trials of the drug early to reduce the chance of hospitalization or death by 89% for adults at risk of developing serious illness.
“If approved, it could be another important weapon in our arsenal to fight the virus along with our vaccines and other treatments, including mollupiravir, which Britain is the world’s first to approve this week. was the first country.” Sajid Javido said.
Last month Britain said it had achieved 250,000 courses of Pfizer’s antiviral pill and 480,000 courses of molnupirvir.
The US company said on Friday it had stopped trials of the drug early to reduce the chance of hospitalization or death by 89% for adults at risk of developing serious illness.
“If approved, it could be another important weapon in our arsenal to fight the virus along with our vaccines and other treatments, including mollupiravir, which Britain is the world’s first to approve this week. was the first country.” Sajid Javido said.
Last month Britain said it had achieved 250,000 courses of Pfizer’s antiviral pill and 480,000 courses of molnupirvir.
.